O4‐02‐06: ORAL TREATMENT WITH RD2 REDUCES Aβ OLIGOMER LOAD, ENHANCES COGNITION, DECELERATES NEURODEGENERATION, REVERSES DISEASE PHENOTYPE IN OLD‐AGED TG AD MICE, AND IS SAFE IN HUMANS
Authors: Dieter Willbold, Janine Kutzsche, Sarah Schemmert, Antje Willuweit,
Published: 2019-10-18
DOI:
10.1016/j.jalz.2019.06.4751
Source:
Full article
Abstract
No abstract found.